Stay updated with breaking news from Although Biomark. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BioMark Diagnostics Inc. an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers is pleased to announce today it has received non-dilutive research funding from a...
BioMark Diagnostics Inc. , an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers, and Rubix LS, a culturally competent patient medical research organization,...
Vancouver, British Columbia--(Newsfile Corp. - December 29, 2023) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF)
BioMark Diagnostics Inc. a clinical and diagnostic laboratory developing a liquid biopsy molecular diagnostic tests with a focus on hard to detect and treat cancers, is pleased to announce today...
Diagnostic Stock News - BioMark (CSE: BUX) Announces Recent New Patent Granted in Canada to Support Its Liquid Biopsy Based Legacy Assay